REGENERON PHARMACEUTICALS, INC. Tax Withholding Paid on Stock Awards
REGENERON PHARMACEUTICALS, INC. (REGN) reported Tax Withholding Paid on Stock Awards of $80.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-07-30
- REGENERON PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $7.60M, a 35.71% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $73.20M, a 1602.33% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $519.20M, a 104.89% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $3.00M, a 97.50% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $532.10M, a 48.29% decline from fiscal 2024.
- REGENERON PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $1.03B, a 46.89% increase from fiscal 2023.
- REGENERON PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $700.60M, a 57.19% increase from fiscal 2022.
- REGENERON PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $445.70M, a 56.84% decline from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month as first filed | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month as first filed | Payment, Tax Withholding, Share-based Payment Arrangement 12 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $80.80M 10-Q · filed 2026-07-30 | $600.00M derived: sum of 3 quarters · filed 2026-07-30 | $603.00M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2026-03-31 | $73.20M 10-Q · filed 2026-04-29 | $592.40M derived: sum of 2 quarters · filed 2026-04-29 | $595.40M derived: sum of 3 quarters · filed 2026-04-29 | $601.00M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-12-31 | $519.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $522.20M derived: sum of 2 quarters · filed 2026-02-04 | $527.80M derived: sum of 3 quarters · filed 2026-07-30 | $532.10M 10-K · filed 2026-02-04 | |||
| 2025-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $8.60M derived: sum of 2 quarters · filed 2026-07-30 | $12.90M 10-Q · filed 2025-10-28 | $266.30M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-06-30 | $5.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $9.90M 10-Q · filed 2026-07-30 | $263.30M derived: sum of 3 quarters · filed 2026-07-30 | $383.50M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-03-31 | $4.30M 10-Q · filed 2026-04-29 | $257.70M derived: sum of 2 quarters · filed 2026-04-29 | $377.90M derived: sum of 3 quarters · filed 2026-04-29 | $689.70M derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2024-12-31 | $253.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $373.60M derived: sum of 2 quarters · filed 2026-02-04 | $685.40M derived: sum of 3 quarters · filed 2026-02-04 | $1.03B 10-K · filed 2026-02-04 | |||
| 2024-09-30 | $120.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $432.00M derived: sum of 2 quarters · filed 2025-10-28 | $775.70M 10-Q · filed 2025-10-28 | $1.23B derived: sum of 4 quarters · filed 2026-02-04 | |||
| 2024-06-30 | $311.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $655.50M 10-Q · filed 2025-08-01 | $1.11B derived: sum of 3 quarters · filed 2026-02-04 | $1.24B derived: sum of 4 quarters · filed 2026-02-04 | |||
| 2024-03-31 | $343.70M 10-Q · filed 2025-04-29 | $801.80M derived: sum of 2 quarters · filed 2026-02-04 | $931.20M derived: sum of 3 quarters · filed 2026-02-04 | $947.30M derived: sum of 4 quarters · filed 2026-02-04 | |||
| 2023-12-31 | $458.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $587.50M derived: sum of 2 quarters · filed 2026-02-04 | $603.60M derived: sum of 3 quarters · filed 2026-02-04 | $700.60M 10-K · filed 2026-02-04 | |||
| 2023-09-30 | $129.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $145.50M derived: sum of 2 quarters · filed 2024-10-31 | $242.50M 10-Q · filed 2024-10-31 | $431.60M derived: sum of 4 quarters · filed 2025-02-05 | |||
| 2023-06-30 | $16.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $113.10M 10-Q · filed 2024-08-01 | $302.20M derived: sum of 3 quarters · filed 2025-02-05 | $411.10M derived: sum of 4 quarters · filed 2025-02-05 | |||
| 2023-03-31 | $97.00M 10-Q · filed 2024-05-02 | $286.10M derived: sum of 2 quarters · filed 2025-02-05 | $395.00M derived: sum of 3 quarters · filed 2025-02-05 | $443.90M derived: sum of 4 quarters · filed 2025-02-05 | |||
| 2022-12-31 | $189.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-05 | $298.00M derived: sum of 2 quarters · filed 2025-02-05 | $346.90M derived: sum of 3 quarters · filed 2025-02-05 | $445.70M 10-K · filed 2025-02-05 | |||
| 2022-09-30 | $108.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $157.80M derived: sum of 2 quarters · filed 2023-11-02 | $256.60M 10-Q · filed 2023-11-02 | $839.00M derived: sum of 4 quarters · filed 2024-02-05 | |||
| 2022-06-30 | $48.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $147.70M 10-Q · filed 2023-08-03 | $730.10M derived: sum of 3 quarters · filed 2024-02-05 | $999.70M derived: sum of 4 quarters · filed 2024-02-05 | |||
| 2022-03-31 | $98.80M 10-Q · filed 2023-05-04 | $681.20M derived: sum of 2 quarters · filed 2024-02-05 | $950.80M derived: sum of 3 quarters · filed 2024-02-05 | $977.00M derived: sum of 4 quarters · filed 2024-02-05 | |||
| 2021-12-31 | $582.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-05 | $852.00M derived: sum of 2 quarters · filed 2024-02-05 | $878.20M derived: sum of 3 quarters · filed 2024-02-05 | $1.03B 10-K · filed 2024-02-05 | |||
| 2021-09-30 | $269.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $295.80M derived: sum of 2 quarters · filed 2022-11-03 | $450.30M 10-Q · filed 2022-11-03 | $478.60M derived: sum of 4 quarters · filed 2023-02-06 | |||
| 2021-06-30 | $26.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $180.70M 10-Q · filed 2022-08-03 | $209.00M derived: sum of 3 quarters · filed 2023-02-06 | $289.90M derived: sum of 4 quarters · filed 2023-02-06 | |||
| 2021-03-31 | $154.50M 10-Q · filed 2022-05-04 | $182.80M derived: sum of 2 quarters · filed 2023-02-06 | $263.70M derived: sum of 3 quarters · filed 2023-02-06 | $680.20M derived: sum of 4 quarters · filed 2023-02-06 | |||
| 2020-12-31 | $28.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-06 | $109.20M derived: sum of 2 quarters · filed 2023-02-06 | $525.70M derived: sum of 3 quarters · filed 2023-02-06 | $680.80M 10-K · filed 2023-02-06 | |||
| 2020-09-30 | $80.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $497.40M derived: sum of 2 quarters · filed 2021-11-04 | $652.50M 10-Q · filed 2021-11-04 | $800.00M derived: sum of 4 quarters · filed 2022-02-07 | |||
| 2020-06-30 | $416.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $571.60M 10-Q · filed 2021-08-05 | $719.10M derived: sum of 3 quarters · filed 2022-02-07 | $719.10M derived: sum of 4 quarters · filed 2022-02-07 | |||
| 2020-03-31 | $155.10M 10-Q · filed 2021-05-06 | $302.60M derived: sum of 2 quarters · filed 2022-02-07 | $302.60M derived: sum of 3 quarters · filed 2022-02-07 | $332.40M derived: sum of 4 quarters · filed 2022-02-07 | |||
| 2019-12-31 | $147.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-07 | $147.50M derived: sum of 2 quarters · filed 2022-02-07 | $177.30M derived: sum of 3 quarters · filed 2022-02-07 | $188.00M 10-K · filed 2022-02-07 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $29.80M derived: sum of 2 quarters · filed 2020-11-05 | $40.50M 10-Q · filed 2020-11-05 | $150.60M derived: sum of 4 quarters · filed 2021-02-08 | |||
| 2019-06-30 | $29.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $40.50M 10-Q · filed 2020-08-05 | $150.60M derived: sum of 3 quarters · filed 2021-02-08 | $195.80M derived: sum of 4 quarters · filed 2021-02-08 | |||
| 2019-03-31 | $10.70M 10-Q · filed 2020-05-05 | $120.80M derived: sum of 2 quarters · filed 2021-02-08 | $166.00M derived: sum of 3 quarters · filed 2021-02-08 | $197.90M derived: sum of 4 quarters · filed 2021-02-08 | |||
| 2018-12-31 | $110.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-08 | $155.30M derived: sum of 2 quarters · filed 2021-02-08 | $187.20M derived: sum of 3 quarters · filed 2021-02-08 | $187.20M 10-K · filed 2021-02-08 | |||
| 2018-09-30 | $45.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $77.10M derived: sum of 2 quarters · filed 2019-11-05 | $77.10M 10-Q · filed 2019-11-05 | $77.10M 10-Q · filed 2018-11-06 | $300.97M derived: sum of 4 quarters · filed 2020-02-07 | ||
| 2018-06-30 | $31.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $31.90M 10-Q · filed 2019-08-06 | $31.85M 10-Q · filed 2018-08-02 | $255.77M derived: sum of 3 quarters · filed 2020-02-07 | $302.16M derived: sum of 4 quarters · filed 2020-02-07 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-07 | $223.87M derived: sum of 2 quarters · filed 2020-02-07 | $270.26M derived: sum of 3 quarters · filed 2020-02-07 | $301.70M derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2017-12-31 | $223.87M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | $270.26M derived: sum of 2 quarters · filed 2020-02-07 | $301.70M derived: sum of 3 quarters · filed 2020-02-07 | $301.70M 10-K · filed 2020-02-07 | $301.69M 10-K · filed 2018-02-08 | ||
| 2017-09-30 | $46.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $77.83M derived: sum of 2 quarters · filed 2018-11-06 | $77.83M 10-Q · filed 2018-11-06 | $174.08M derived: sum of 4 quarters · filed 2019-02-07 | |||
| 2017-06-30 | $31.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $31.44M 10-Q · filed 2018-08-02 | $127.68M derived: sum of 3 quarters · filed 2019-02-07 | $129.62M derived: sum of 4 quarters · filed 2019-02-07 | |||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-04 | $96.25M derived: sum of 2 quarters · filed 2019-02-07 | $98.19M derived: sum of 3 quarters · filed 2019-02-07 | $142.16M derived: sum of 4 quarters · filed 2019-02-07 | |||
| 2016-12-31 | $96.25M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-07 | $98.19M derived: sum of 2 quarters · filed 2019-02-07 | $142.16M derived: sum of 3 quarters · filed 2019-02-07 | $143.20M 10-K · filed 2019-02-07 | $143.18M 10-K · filed 2017-02-09 | ||
| 2016-09-30 | $1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $45.91M derived: sum of 2 quarters · filed 2017-11-08 | $46.95M 10-Q · filed 2017-11-08 | $135.82M derived: sum of 4 quarters · filed 2018-02-08 | |||
| 2016-06-30 | $43.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $45.01M 10-Q · filed 2017-08-03 | $133.88M derived: sum of 3 quarters · filed 2018-02-08 | $169.62M derived: sum of 4 quarters · filed 2018-02-08 | |||
| 2016-03-31 | $1.04M 10-Q · filed 2017-05-04 | $89.91M derived: sum of 2 quarters · filed 2018-02-08 | $125.65M derived: sum of 3 quarters · filed 2018-02-08 | $140.39M derived: sum of 4 quarters · filed 2018-02-08 | |||
| 2015-12-31 | $88.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-08 | $124.61M derived: sum of 2 quarters · filed 2018-02-08 | $139.34M derived: sum of 3 quarters · filed 2018-02-08 | $160.54M 10-K · filed 2018-02-08 | |||
| 2015-09-30 | $35.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $50.48M derived: sum of 2 quarters · filed 2016-11-04 | $71.67M 10-Q · filed 2016-11-04 | $163.39M derived: sum of 4 quarters · filed 2017-02-09 | |||
| 2015-06-30 | $14.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $35.93M 10-Q · filed 2016-08-04 | $127.65M derived: sum of 3 quarters · filed 2017-02-09 | $238.52M derived: sum of 4 quarters · filed 2017-02-09 | |||
| 2015-03-31 | $21.19M 10-Q · filed 2016-05-05 | $112.91M derived: sum of 2 quarters · filed 2017-02-09 | $223.79M derived: sum of 3 quarters · filed 2017-02-09 | $225.69M derived: sum of 4 quarters · filed 2017-02-09 | |||
| 2014-12-31 | $91.72M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-09 | $202.59M derived: sum of 2 quarters · filed 2017-02-09 | $204.50M derived: sum of 3 quarters · filed 2017-02-09 | $267.58M 10-K · filed 2017-02-09 | |||
| 2014-09-30 | $110.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $112.78M derived: sum of 2 quarters · filed 2015-11-04 | $175.87M 10-Q · filed 2015-11-04 | $204.59M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2014-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $64.99M 10-Q · filed 2015-08-04 | $93.72M derived: sum of 3 quarters · filed 2016-02-11 | $186.94M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2014-03-31 | $63.09M 10-Q · filed 2015-05-07 | $91.81M derived: sum of 2 quarters · filed 2016-02-11 | $185.04M derived: sum of 3 quarters · filed 2016-02-11 | $255.09M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2013-12-31 | $28.73M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $121.95M derived: sum of 2 quarters · filed 2016-02-11 | $192.00M derived: sum of 3 quarters · filed 2016-02-11 | $195.09M 10-K · filed 2016-02-11 | |||
| 2013-09-30 | $93.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $163.27M derived: sum of 2 quarters · filed 2014-11-04 | $166.36M 10-Q · filed 2014-11-04 | $258.18M derived: sum of 4 quarters · filed 2015-02-12 | |||
| 2013-06-30 | $70.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $73.14M 10-Q · filed 2014-08-05 | $164.96M derived: sum of 3 quarters · filed 2015-02-12 | $174.99M derived: sum of 4 quarters · filed 2015-02-12 | |||
| 2013-03-31 | $3.08M 10-Q · filed 2014-05-08 | $94.91M derived: sum of 2 quarters · filed 2015-02-12 | $104.94M derived: sum of 3 quarters · filed 2015-02-12 | $117.31M derived: sum of 4 quarters · filed 2015-02-12 | |||
| 2012-12-31 | $91.83M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $101.86M derived: sum of 2 quarters · filed 2015-02-12 | $114.22M derived: sum of 3 quarters · filed 2015-02-12 | $163.30M 10-K · filed 2015-02-12 | |||
| 2012-09-30 | $10.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $22.40M derived: sum of 2 quarters · filed 2013-11-05 | $71.47M 10-Q · filed 2013-11-05 | $80.24M derived: sum of 4 quarters · filed 2014-02-13 | |||
| 2012-06-30 | $12.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $61.44M 10-Q · filed 2013-08-06 | $70.21M derived: sum of 3 quarters · filed 2014-02-13 | $81.81M derived: sum of 4 quarters · filed 2014-02-13 | |||
| 2012-03-31 | $49.08M 10-Q · filed 2013-05-03 | $57.84M derived: sum of 2 quarters · filed 2014-02-13 | $69.45M derived: sum of 3 quarters · filed 2014-02-13 | $73.09M derived: sum of 4 quarters · filed 2014-02-13 | |||
| 2011-12-31 | $8.76M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13 | $20.37M derived: sum of 2 quarters · filed 2014-02-13 | $24.02M derived: sum of 3 quarters · filed 2014-02-13 | $25.08M 10-K · filed 2014-02-13 | |||
| 2011-09-30 | $11.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $15.25M derived: sum of 2 quarters · filed 2012-10-24 | $16.32M 10-Q · filed 2012-10-24 | ||||
| 2011-06-30 | $3.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | $4.71M 10-Q · filed 2012-07-25 | |||||
| 2011-03-31 | $1.06M 10-Q · filed 2012-04-26 | ||||||
| 2010-12-31 | $3.80M 10-K · filed 2013-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |